The Influence of Polyendocrine Metabolic Ovarian Syndrome on Training Adaptations and Athletic Performance
DOI:
https://doi.org/10.12775/QS.2026.62.73200Keywords
Polyendocrine Metabolic Ovarian Syndrome Polycystic Ovary Syndrome, PMOS, PCOS, hyperandrogenism, athletic performance, exercise, training adaptations, female athletesAbstract
Background: Polyendocrine Metabolic Ovarian Syndrome (PMOS), previously known as
Polycystic Ovary Syndrome (PCOS), is one of the most common endocrine disorders affecting
women of reproductive age. While regular physical activity is widely recognized as a
cornerstone of PMOS management, increasing evidence suggests that the syndrome itself may
influence training adaptations and athletic performance. The characteristic hormonal profile of
PMOS, particularly hyperandrogenism, may confer physiological advantages relevant to
athletic performance. Increased androgen concentrations have been linked to greater muscle
mass, enhanced strength and power production, improved oxygen transport capacity, and
favorable adaptations to training, which may contribute to superior athletic performance in
some women with PMOS.
Aim: The aim of this narrative review was to summarise and critically discuss the current
evidence regarding the relationship between PMOS, training adaptations, and athletic
performance.
Material and methods: A narrative review summarising and discussing evidence from
observational studies (including case-control and cohort studies), systematic reviews, and
meta-analyses published between 2015 and 2026, was conducted. The critical analysis focused
on the physiological effects of hyperandrogenism in PMOS, training adaptations, athletic
performance, and healthrelated factors influencing exercise capacity in women with PMOS.
Conclusions: PMOS appears to have both beneficial and detrimental effects on exercise
performance. While hyperandrogenism may confer certain physiological advantages,
metabolic and psychological challenges associated with the syndrome may limit athletic
potential. Further longitudinal and mechanistic studies are required to better understand the
influence of PMOS on training responses and to develop individualized exercise
recommendations for affected athletes.
References
[1]
Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, Norman RJ, Mousa A, Joham AE. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2447-2469. doi: 10.1210/clinem/dgad463. PMID: 37580314; PMCID: PMC10505534.
https://doi.org/10.1210/clinem/dgad463
[2]
Teede HJ, Khomami MB, Morman R, et al; Global Name Change Consortium. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet 2026:S0140-6736(26)00717-8
DOI: 10.1016/S0140-6736(26)00717-8
[3]
Unluhizarci K, Karaca Z, Kelestimur F. Role of insulin and insulin resistance in androgen excess disorders. World J Diabetes. 2021 May 15;12(5):616-629. doi: 10.4239/wjd.v12.i5.616. PMID: 33995849; PMCID: PMC8107978.
https://doi.org/10.4239/wjd.v12.i5.616
[4]
Gautam R, Maan P, Jyoti A, Kumar A, Malhotra N, Arora T. The Role of Lifestyle Interventions in PCOS Management: A Systematic Review. Nutrients. 2025 Jan 16;17(2):310. doi: 10.3390/nu17020310. PMID: 39861440; PMCID: PMC11767734.
DOI: 10.3390/nu17020310
[5]
Hirschberg AL. Female hyperandrogenism and elite sport. Endocr Connect. 2020 Apr;9(4):R81- R92. doi: 10.1530/EC-19-0537. PMID: 32197237; PMCID: PMC7159262.
https://doi.org/10.1530/ec-19-0537
[6]
Hirschberg AL. Female Hyperandrogenism in Elite Sports and the Athletic Triad. Semin Reprod Med. 2022 Mar;40(1-02):32-41. doi: 10.1055/s-0041-1736337. Epub 2021 Oct 11. PMID: 34634825.
https://doi.org/10.1055/s-0041-1736337
[7]
Dong J, Rees DA. Polycystic ovary syndrome: pathophysiology and therapeutic opportunities. BMJ Med. 2023 Oct 12;2(1):e000548. doi: 10.1136/bmjmed-2023-000548. PMID: 37859784; PMCID: PMC10583117.
https://doi.org/10.1136/bmjmed-2023-000548
[8]
Zhao H, Zhang J, Cheng X, Nie X, He B. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res. 2023 Jan 11;16(1):9. doi: 10.1186/s13048-022-01091-0. PMID: 36631836; PMCID: PMC9832677.
https://doi.org/10.1186/s13048-022-01091-0
[9]
Bermon S, Garnier PY. Serum androgen levels and their relation to performance in track and field: mass spectrometry results from 2127 observations in male and female elite athletes. Br J Sports Med. 2017 Sep;51(17):1309-1314. doi: 10.1136/bjsports-2017-097792. Epub 2017 Jul 3. Erratum in: Br J Sports Med. 2021 Sep;55(17):e7. doi: 10.1136/bjsports-2017-097792corr1. PMID: 28673896.
https://doi.org/10.1136/bjsports-2017-097792
[10]
Bermon S, Hirschberg AL, Kowalski J, Eklund E. Serum androgen levels are positively correlated with athletic performance and competition results in elite female athletes. Br J Sports Med. 2018 Dec;52(23):1531-1532. doi: 10.1136/bjsports-2018-099700. Epub 2018 Jul 7. PMID: 29982225.
https://doi.org/10.1136/bjsports-2018-099700
[11]
Handelsman DJ, Hirschberg AL, Bermon S. Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance. Endocr Rev. 2018 Oct 1;39(5):803-829. doi: 10.1210/er.2018-00020. PMID: 30010735; PMCID: PMC6391653.
https://doi.org/10.1210/er.2018-00020
[12]
Sacinti HG, Ibanoglu MC, Celik GE, Sanisoglu Y, Ustun YE. Evaluation of muscle strength assessment in adolescent polycystic ovary syndrome: a case control study. BMC Womens Health. 2026 Jan 30;26(1):137. doi: 10.1186/s12905-026-04275-8. PMID: 41618326; PMCID: PMC12933921.
https://doi.org/10.1186/s12905-026-04275-8
[13]
Caliskan Guzelce E, Eyupoglu D, Torgutalp S, Aktoz F, Portakal O, Demirel H, Yildiz BO. Is muscle mechanical function altered in polycystic ovary syndrome? Arch Gynecol Obstet. 2019 Sep;300(3):771-776. doi: 10.1007/s00404-019-05229-2. Epub 2019 Jul 1. PMID: 31263987.
https://doi.org/10.1007/s00404-019-05229-2
[14]
Bushell A, Crespi BJ. The evolutionary basis of elevated testosterone in women with polycystic ovary syndrome: an overview of systematic reviews of the evidence. Front Reprod Health. 2024 Sep 30;6:1475132. doi: 10.3389/frph.2024.1475132. PMID: 39403367; PMCID: PMC11471738.
DOI: 10.3389/frph.2024.1475132
[15]
Łagowska K, Kapczuk K. Testosterone concentrations in female athletes and ballet dancers with menstrual disorders. Eur J Sport Sci. 2016;16(4):490-7. doi: 10.1080/17461391.2015.1034786. Epub 2015 May 8. PMID: 25951882.
https://doi.org/10.1080/17461391.2015.1034786
[16]
La Vignera S, Condorelli RA, Cannarella R, Duca Y, Calogero AE. Sport, doping and female fertility. Reprod Biol Endocrinol. 2018 Nov 19;16(1):108. doi: 10.1186/s12958-018-0437-8. PMID: 30449281; PMCID: PMC6241032.
https://doi.org/10.1186/s12958-018-0437-8
[17]
McDonnell T, Cussen L, McIlroy M, O'Reilly MW. Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2022 Jul 18;13:20420188221113140. doi: 10.1177/20420188221113140. PMID: 35874313; PMCID: PMC9297442.
https://doi.org/10.1177/20420188221113140
[18]
Stepto NK, Hiam D, Gibson-Helm M, Cassar S, Harrison CL, Hutchison SK, Joham AE, Canny BJ, Moreno-Asso A, Strauss BJ, Hatzirodos N, Rodgers RJ, Teede HJ. Exercise and insulin resistance in PCOS: muscle insulin signalling and fibrosis. Endocr Connect. 2020 Apr;9(4):346- 359. doi: 10.1530/EC-19-0551. PMID: 32229703; PMCID: PMC7219141.
https://doi.org/10.1530/ec-19-0551
[19]
Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017 May 1;32(5):1075-1091. doi: 10.1093/humrep/dex044. PMID: 28333286.
https://doi.org/10.1093/humrep/dex044
[20]
Infante-Cano M, García-Muñoz C, Matias-Soto J, Pineda-Escobar S, Villar-Alises O, MartinezCalderon J. The prevalence and risk of anxiety and depression in polycystic ovary syndrome: an overview of systematic reviews with meta-analysis. Arch Womens Ment Health. 2025 Jun;28(3):475-489. doi: 10.1007/s00737-024-01526-1. Epub 2024 Oct 25. PMID: 39453529.
https://doi.org/10.1007/s00737-024-01526-1
[21]
Dybciak P, Raczkiewicz D, Humeniuk E, Powrózek T, Gujski M, Małecka-Massalska T, Wdowiak A, Bojar I. Depression in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. J Clin Med. 2023 Oct 10;12(20):6446. doi: 10.3390/jcm12206446. PMID: 37892583; PMCID: PMC10607337
https://doi.org/10.3390/jcm12206446
[22]
Homa LD, Burger LL, Cuttitta AJ, Michele DE, Moenter SM. Voluntary Exercise Improves Estrous Cyclicity in Prenatally Androgenized Female Mice Despite Programming Decreased Voluntary Exercise: Implications for Polycystic Ovary Syndrome (PCOS). Endocrinology. 2015 Dec;156(12):4618-28. doi: 10.1210/en.2015-1593. Epub 2015 Sep 10. PMID: 26360506; PMCID: PMC4655213.
https://doi.org/10.1210/en.2015-1593
[23]
Clark RV, Wald JA, Swerdloff RS, Wang C, Wu FCW, Bowers LD, Matsumoto AM. Large divergence in testosterone concentrations between men and women: Frame of reference for elite athletes in sex-specific competition in sports, a narrative review. Clin Endocrinol (Oxf). 2019 Jan;90(1):15-22. doi: 10.1111/cen.13840. Epub 2018 Sep 27. Erratum in: Clin Endocrinol (Oxf). 2019 Sep;91(3):471-473. doi: 10.1111/cen.14068. PMID: 30136295.
https://doi.org/10.1111/cen.13840
[24]
Bowman-Smart H, Savulescu J, O'Connell M, Sinclair A. World Athletics regulations unfairly affect female athletes with differences in sex development. J Philos Sport. 2024 Jan 2;51(1):29- 53. doi: 10.1080/00948705.2024.2316294. Epub 2024 Mar 5. PMID: 39015654; PMCID: PMC7616231.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Gabriela Pirga, Gabriela Chwajta, Gabriela Kaczor, Weronika Cichocka, Barbara Cepielik, Martyna Antos, Filip chmielnicki, Kacper Paczosa, Maciej Ostolski, Klaudia Jędruszko

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 79
Number of citations: 0